Management of premenstrual syndrome: evidence-based guidelines

This review uses as its basis the green top Guideline No 48 on the management of premenstrual syndrome. The aim of the guideline was to review the diagnosis and management of premenstrual syndrome (PMS), in particular, the evidence for pharmacological and non-pharmacological treatments. The key aspects of the guidelines will be discussed in an easily digestible format and bring some of the aspects of the database up to date according to the new evidence base. Additionally, the review will take a wider view of the situation with particular emphasis on recent attempts to achieve a global consensus on definitions and management. The development of a consensus and guidelines on the definition and management of PMS are essential to encourage acceptance of condition by patients/health professionals and regulatory authorities.